March 5, 2026
1 min read

Forma Life Sciences launches with oral solid dose focus, joining class of new CDMOs

Forma Life Sciences, which inherited BioDuro’s California operations earlier this year, officially launched as a CDMO with a focus on oral solid dosage drugs this week.

Leave a Reply

Your email address will not be published.

Previous Story

STAT+: RFK Jr. has wide discretion to choose evidence to support vaccine decisions, DOJ argues

Next Story

A month in, TrumpRx falls short of president’s grand promises

Previous Story

STAT+: RFK Jr. has wide discretion to choose evidence to support vaccine decisions, DOJ argues

Next Story

A month in, TrumpRx falls short of president’s grand promises

Latest from Blog

ROFI Drives New Approach to Crop Nutrition

With input costs continuing to pressure farm budgets, some growers are making difficult decisions to reduce fertilizer application rates. While that strategy may ease upfront expenses, it is also accelerating a broader
Go toTop